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Abstract
Recent studies indicate that the methylation state of histones can be dynamically regulated by
histone methyltransferases and demethylases1,2. The H3K9-specific demethylase Jhdm2a (also
known as Jmjd1a and Kdm3a) has an important role in nuclear hormone receptor-mediated gene
activation and male germ cell development3,4. Through disruption of the Jhdm2a gene in mice,
here we demonstrate that Jhdm2a is critically important in regulating the expression of metabolic
genes. The loss of Jhdm2a function results in obesity and hyperlipidemia in mice. We provide
evidence that the loss of Jhdm2a function disrupts β-adrenergic-stimulated glycerol release and
oxygen consumption in brown fat, and decreases fat oxidation and glycerol release in skeletal
muscles. We show that Jhdm2a expression is induced by β-adrenergic stimulation, and that
Jhdm2a directly regulates peroxisome proliferator-activated receptor α (Ppara) and Ucp1
expression. Furthermore, we demonstrate that β-adrenergic activation-induced binding of Jhdm2a
to the PPAR responsive element (PPRE) of the Ucp1 gene not only decreases levels of H3K9me2
(dimethylation of lysine 9 of histone H3) at the PPRE, but also facilitates the recruitment of Pparγ
and Rxrα and their co-activators Pgc1aα(also known as Ppargc1a), CBP/ p300 (Crebbp) and Src1
(Ncoa1) to the PPRE. Our studies thus demonstrate an essential role for Jhdm2a in regulating
metabolic gene expression and normal weight control in mice.
Using a hypomorphic Jhdm2a knockout model, we have previously shown an important role
for the H3K9 demethylase Jhdm2a in spermatogenesis3. To further characterize the
biological function of this demethylase, we created a new mouse line with the catalytic
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Figure S7. Jhdm2a deficiency affects PPAR signaling pathway in muscle.
Affymetrix microarray fold change data from RNA samples corresponding to Jhdm2a KO muscle vs. WT muscle was overlayed onto
the PPAR signaling pathway using GenMAPP 2 software. Entities are colored by expression fold change in KO versus WT as
indicated.



















jumonji C domain floxed by loxP sites (Supplementary Fig. 1a). Heterozygous mice were
generated by crossing 3lox mice with EIIa-Cre transgenic mice (Supplementary Fig. 1a, b).
Jhdm2a1lox/1lox (knockout) mice were obtained by intercrossing Jhdm2a1lox/+ mice, and
were confirmed by PCR and western blot analysis (Supplementary Fig. 1b, c). Similar to the
hypomorphic Jhdm2a mice, the complete knockout mice exhibit spermatogenesis defects
(data not shown). Interestingly, the Jhdm2a knockout mice become obese in adulthood when
compared to their wild-type littermates (Fig. 1a and Supplementary Fig. 2). The obese
phenotype is also observed in Jhdm2a knockout mice backcrossed onto a C57BL/6
background (data not shown), as well as in the hypomorphic Jhdm2a mice on a mixed
129SV/Ola and C57BL/6 background (Supplementary Fig. 3), indicating that Jhdm2a
deficiency leads to obesity irrespective of the genetic background. Consistent with a
potential role for Jhdm2a in energy homeostasis, Jhdm2a is expressed at a relatively higher
level in organs responsive to sympathetic nerve activity, such as brown adipose tissue
(BAT) and skeletal muscle (Supplementary Fig. 4). In contrast, Jhdm2a expression in brain
is almost undetectable (Supplementary Fig. 4).
Magnetic resonance imaging (MRI) analysis revealed marked body fat deposition in 4-
month-old knockout mice (Supplementary Fig. 2c). However, non-adipose tissues (lean)
were comparable between wild-type and Jhdm2a knockout mice (Supplementary Fig. 2c).
Similar to that observed in human obesity, large fat droplets are observed in white adipose
tissue, as well as in muscle and liver (Fig. 1b). In addition, serum lipid content—including
free fatty acid, triglyceride and total cholesterol—is significantly higher in the knockout
mice (Fig. 1c). Furthermore, a high-fat diet accelerated the onset of obesity in the knockout
mice (Fig. 1d). Collectively, these findings suggest that the loss of Jhdm2a function results
in abnormal fat metabolism and obesity.
The body weight of an animal is maintained through a balance between food intake and
energy expenditure5,6. To understand how Jhdm2a deficiency results in obesity, we first
analysed food intake before the onset of obesity using 6-week-old mice, and found that
caloric intake is not increased in the Jhdm2a knockout mice (Supplementary Fig. 5a).
Similarly, the 16-week-old Jhdm2a knockout mice did not show an increased food intake,
regardless of the fat content present in the diet (Supplementary Fig. 5b). In addition, the
serum leptin level is not significantly altered in 6-week-old Jhdm2a knockout mice before
they become obese (Supplementary Fig. 5c).
Given that the human counterpart of mouse Jhdm2a has been previously demonstrated to
function as a transcriptional co-activator4, we compared the gene expression profiles of
wild-type and Jhdm2a knockout skeletal muscles using Affymetrix microarray technology.
We chose to perform the analysis in skeletal muscle because of the high expression of
Jhdm2a and also its role in energy expenditure. Of the 43,000 probes analysed, 602 probes
(1.4%) were downregulated at least twofold and 220 probes (0.05%) were upregulated at
least twofold in Jhdm2a knockout soleus muscle. Gene ontology enrichment analysis
indicated that the largest proportion of downregulated genes were involved in metabolic
processes (P = 0.03) (Supplementary Fig. 6a), whereas genes involved in lipid metabolism
were the most enriched (P < 1 × 10−4) (Supplementary Fig. 6b–e). Interestingly, pathway
analysis showed that a significant proportion of the genes involved in PPAR signalling are
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downregulated in response to the Jhdm2a knockout (P < 1 × 10−11) (Supplementary Fig. 7).
Quantitative PCR with reverse transcription (qRT–PCR) confirmed the downregulation of
many genes involved in the PPAR pathway, including Ppara, Ucp2, MCAD (also known as
Acadm), LCAD (Acadl), VLCAD (Acadvl) and Aqp7 but not Ppard (Fig. 2a). Consistent with
the fact that multiple rate-limiting enzymes for fatty acid oxidation, such as MCAD, LCAD
and VLCAD, were downregulated in the Jhdm2a knockout skeletal muscle, β-oxidation of
palmitic acid was significantly decreased in primary myocytes derived from the Jhdm2a
knockout newborn (Fig. 2b). Consistent with downregulation of Aqp7 (Fig. 2a), glycerol
release in response to a β-adrenergic agonist is impaired in the Jhdm2a knockout soleus
muscle (Fig. 2c). These results are consistent with previous demonstrations that Pparα has
an essential involvement in fatty acid metabolism7–9. Notably, the results also indicate that
the impaired expression of Pparα and its downstream target genes might be one of the
causes of abnormal fat accumulation in the Jhdm2a knockout mice, because previous studies
have shown that Ppara-deficient mice are prone to diet-induced obesity9 and that Aqp7
deficiency causes obesity in adult mice10.
To understand how the loss of Jhdm2a function results in the downregulation of Ppara and
its target genes, we analysed the presence of Jhdm2a around defined PPRE sequences using
chromatin immunoprecipitation (ChIP) 11–14. Results indicate that Jhdm2a binds to the
PPRE of Ppara, but not to the PPREs of MCAD, Acox1 or Scp2 (Fig. 2d). Consistent with
the function of Jhdm2a as an H3K9me2 demethylase, the level of H3K9me2 at the region
encompassing the PPRE of the Ppara gene is significantly increased in the Jhdm2a
knockout muscle cells (Fig. 2e). To demonstrate that the reduced Pparα expression in
Jhdm2a knockout muscle cells is a cell-intrinsic effect, we performed qRT–PCR and ChIP
analysis using in vitro cultured primary myocytes derived from newborn wild-type and
knockout mice. Results shown in Fig. 2f demonstrate that Ppara is decreased by 50% in
Jhdm2a knockout myocytes. ChIP analysis showed increased levels of H3K9me2 at the
Ppara PPRE of Jhdm2a knockout myocytes (Fig. 2g). Notably, both Ppara expression and
promoter H3K9me2 levels at PPRE can be partially rescued by overexpression of human
JHDM2A (Fig. 2f, g). These data collectively support the notion that Ppara is a direct target
of Jhdm2a and that Jhdm2a plays an important part in lipid metabolism in skeletal muscle
cells.
In addition to skeletal muscle, Jhdm2a is also highly expressed in BAT (Supplementary Fig.
4). Jhdm2a deficiency resulted in the enlargement and accumulation of lipid droplets in the
BAT (Supplementary Fig. 8). Consistent with the BAT abnormities, Jhdm2a knockout mice
showed defective adaptive thermogenesis (Fig. 3a). The phenotypic similarity between
Jhdm2a knockout mice and mice lacking β-adrenergic receptors15 raises the possibility that
Jhdm2a might be a critical factor in β-adrenergic signalling. Consistent with this notion, β-
adrenergic-stimulated oxygen consumption and glycerol release are greatly reduced in the
Jhdm2a knockout BAT (Fig. 3b, c). In addition, genes involved in mitochondrial functions
including Ppara, Ucp3, Cpt2 and LCAD are also decreased in the Jhdm2a knockout BAT
(Fig. 3d). Furthermore, analysis of the expression of Ucp1 and Dio2, two key genes
involved in thermogenesis in BAT16, demonstrated that cold-induced Ucp1 upregulation is
almost completely blocked although Dio2 induction is not affected (Fig. 3e). Given the
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critical function of Ucp1 in cold sensitivity17, defective activation of Ucp1 by β-adrenergic
signalling is probably one contributing factor of defective thermogenesis in the Jhdm2a
knockout BAT.
As one of the most important molecules involved in cold-induced thermogenesis in brown
fat, the transcriptional regulation of Ucp1 has been extensively characterized16. In addition
to Pparα and Pparγ, other transcription factors and co-activators known to be involved in
Ucp1 activation include Rxrα, Atf2, p300, Src1 and Pgc1α. qRT– PCR demonstrates that
the expression of these genes is not significantly altered in the Jhdm2a knockout BAT
(Supplementary Fig. 9), however cold-induced upregulation of Pparα is defective in
knockout BAT (Supplementary Fig. 9). This indicates that the defect in cold-induced Ucp1
induction in Jhdm2a knockout BAT might be mediated through Pparα, which is a direct
target of Jhdm2a in muscle cells (Fig. 2d). Given that cold-induced Ucp1 upregulation is
intact in the Pparα deficient mice18, we explored the possibility that Jhdm2a directly
regulates Ucp1 expression in response to cold exposure.
To ascertain that the effect of Jhdm2a on Ucp1 expression is cell intrinsic, we performed
short-hairpin RNA (shRNA)-mediated Jhdm2a knockdown in the brown adipose cell line
HIB1B using lentivirus-based shRNA. Although Jhdm2a knockdown does not affect HIB1B
differentiation (data not shown), the differentiated knockdown cells have impaired Ucp1
activation by isoproterenol (ISO), a general β-adrenergic receptor agonist (Fig. 4a),
consistent with the result obtained in Jhdm2a knockout BAT (Fig. 3e). Importantly,
enforced overexpression of human JHDM2A in the knockdown cells partially rescued Ucp1
expression (Fig. 4b). Interestingly, both the messenger RNA and protein levels of Jhdm2a
are upregulated in response to β-adrenergic receptor activation (Fig. 4c), supporting Jhdm2a
as an integral component of the β-adrenergic signalling pathway. Similar to that observed in
mouse brown fat tissues, the expression of the transcription factors and co-activators
involved in Ucp1 activation is not significantly altered in the HIB1B knockdown cells
(Supplementary Fig. 10a). ISO-induced upregulation of Pgc1α is also maintained in HIB1B
knockdown cells (Supplementary Fig. 10a). We next explored the possibility that Jhdm2a
directly regulates Ucp1 expression. ChIP analysis demonstrated that Jhdm2a can bind to the
Ucp1 enhancer region19 in a β-adrenergic receptor ligand-dependent manner. The binding is
site-specific as Jhdm2a was not detected within the Ucp1 coding region (Fig. 4d, amplicon
B). As expected, the H3K9me2 levels at the Jhdm2a binding site are specifically decreased
in response to ISO treatment and this effect is abolished in the Jhdm2a knockdown cells
(Fig. 4e). Notably, enforced overexpression of human JHDM2A in the knockdown cells
partially rescued the increased H3K9me2 level in an ISO-dependent manner (Fig. 4e).
Collectively, these results indicate that Jhdm2a expression is regulated by the β-adrenergic
signalling pathway and that Jhdm2a contributes to Ucp1 activation by serving as a co-
activator in response to β-adrenergic receptor activation.
Previous studies have indicated that Pparγ- and Rxrα-mediated Ucp1 activation requires the
recruitment of co-activators20. In addition to removing the repressive H3K9me2 mark at the
Ucp1 enhancer, Jhdm2a could contribute to Ucp1 activation by affecting the recruitment of
transcription factors and co-activators. To examine this possibility, we analysed the effect of
the loss of Jhdm2a on the recruitment of transcription factors (Pparγ, Rxrα and Atf2) and
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co-activators (Pgc1α, CBP/p300 and Src1). We found that the binding of Pparγ, Rxrα and
Atf2 to the Ucp1 enhancer is increased in response to ISO treatment (Fig. 4f). However,
theenhanced binding by Pparγ and Rxrα disappeared in the Jhdm2a knockdown cells (Fig.
4f). Similar results are also observed for the co-activators (Fig. 4g). Given that Jhdm2a
knockdown does not alter the protein levels of these transcription factors and co-activators
(Supplementary Fig. 10b), the simplest explanation of the results is that Jhdm2a facilitates
their recruitment in response to β-adrenergic stimulation. Our results, together with the
previous demonstration that Pparγ recruitment to Ucp1 enhancer is blocked in pCip (also
known as Ncoa3) and Src1 double knockout BAT20, indicate that the binding of
transcription factors and co-activators to the Ucp1 enhancer affect one another. Collectively,
our data suggest that Jhdm2a contributes to β-adrenergic-stimulated Ucp1 activation by
maintaining a low level of H3K9me2 at the Ucp1 enhancer region, and by augmenting the
recruitment of Pparγ and Rxrα and their co-activators to the Ucp1 enhancer element.
In this study we identified Ppara and Ucp1, two of the important genes involved in
controlling energy balance, as direct targets of Jhdm2a. Notably, the expression of these two
genes, as well as Jhdm2a, is induced after β-adrenergic stimulation16,21 (Figs 3e, 4c and
Supplementary Fig. 9). Thus we propose that Jhdm2a mediates β-adrenergic signalling on
the basis of the systemic energy demand. Consistent with this notion, Jhdm2a knockout
mice and mice lacking β-adrenergic receptors have similar phenotypes that include defects
in BAT function, cold intolerance, decreased oxygen consumption (Supplementary Fig. 11)
and obesity without hyperphagia. Although the Jhdm2a deficiency does not affect metabolic
hormone levels (Supplementary Fig. 12), the obesity phenotype supports an important role
for Jhdm2a in regulating systemic metabolic control including Pparα and β-adrenergic
signalling pathways. Although the entire mechanism underlying the phenotype reported here
remains elusive, it is interesting to note that this is a unique mouse model in which a single
epigenetic factor deficiency results in obesity.
METHODS SUMMARY
Animal experiments
All animal experiments were performed according to procedures approved by the
Institutional Animal Care and Use Committee.
Cell culture, viral infection and differentiation
Primary myoblasts were established from neonatal mice as reported22. To generate a
Jhdm2a knockdown HIB1B cell line, undifferentiated cells were infected with a lentiviral
virus expressing an shRNA for Jhdm2a or control. The shRNA sequence for Jhdm2a was
5’-GCAGGTGTCACTAGCCTTAAT-3’. The differentiation of HIB1B cells was performed
as previously described23. For the overexpression of the human JHDM2A gene, cells were
infected with a retroviral vector expressing Flag– JHDM2A or a control before the cells
were subjected to differentiation.
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All results are presented as the mean and standard error. Statistical comparisons were by
Student's t-tests. Statistical significance was set at P < 0.05.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Jhdm2a-deficient mice exhibit obesity phenotypes
a, Jhdm2a knockout mice exhibit an obesity phenotype. Shown is a representative
photograph of 7-month-old littermates. b, Abnormal fat accumulation in organs of
Jhdm2a−/− mice. Haematoxylin and eosin (H&E) staining of white adipose, muscle and liver
derived from 7-month-old littermates. Arrowheads indicate the intramuscle fat deposition.
Scale bars, 50 μm. c, Jhdm2a deficiency results in hyperlipidemia as indicated by the
increased levels of serum free fatty acid (FFA), triglyceride (TG) and total cholesterol
(TCHO) in Jhdm2a−/− (n = 16) compared with Jhdm2a+/+ (n = 10) mice. *P < 0.05; **P <
0.01. d, Growth curve of littermates fed with a high-fat diet (HFD) or normal chow. Solid
lines, high-fat diet group; dotted lines, normal chow group. BW, body weight. n = 4 per
group; *P < 0.03. Data are mean and s.e.m.
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Figure 2. Jhdm2a deficiency affects the expression of metabolic genes and impairs β-oxidation
and glycerol release in skeletal muscle
a, qRT–PCR analysis confirms the decreased expression of genes that are involved in PPAR
signalling in the Jhdm2a knockout soleus muscles. *P < 0.05. b, Jhdm2a deficiency results
in decreased β-oxidation in primary muscle cells. n = 5 per group; **P < 0.01. c, Jhdm2a
deficiency results in decreased glycerol release in isolated soleus muscle. n = 5 per group;
**P < 0.01. d, Jhdm2a directly binds to the PPRE of the Ppara enhancer. Soleus muscles
were used for ChIP followed by qRT–PCR. Results are normalized to IgG. *P < 0.05. e,
Jhdm2a deficiency results in increased H3K9me2 levels within the Ppara enhancer. The
signal in wild-type cells is set as 1. *P < 0.05. f, Cultured Jhdm2a knockout myocytes show
decreased Ppara expression, which can be partially restored by overexpression of the
JHDM2A gene. Wild-type primary cultured myocytes served as a control for qRT–PCR. *P
< 0.05. g, ChIP analysis in the primary cultured myocytes. Jhdm2a deficiency causes the
increase of the H3K9me2 level at the PPRE of the Ppara enhancer. This change can be
partially rescued by overexpression of Jhdm2a. The signal in wild-type cells is set as 1. *P <
0.05. Data are mean and s.e.m.
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Figure 3. Jhdm2a deficiency results in functional defects in BAT
a, Jhdm2a deficiency impairs the ability of mice to maintain body temperature when
exposed to cold. Shown is the body temperature of 12-week-old mice at different times after
cold exposure (4 °C). n = 5 per group; *P < 0.05. b, Jhdm2a deficiency impairs ISO-induced
oxygen consumption in BAT. *P < 0.05. c, Jhdm2a deficiency results in decreased glycerol
release in BAT. *P < 0.05. d, qRT–PCR analysis demonstrates decreased expression of
genes involved in mitochondrial function in the Jhdm2a knockout BAT. *P < 0.05. e,
Jhdm2a deficiency impairs cold-induced activation of Ucp1, but not Dio2, in BAT. n > 4 per
group. The mRNA level is normalized by 36B4 mRNA, and the relative quantity in
Jhdm2a+/+ BAT at 20 °C is defined as 1. **P < 0.01. Data are mean and s.e.m.
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Figure 4. Jhdm2a is induced by β-adrenergic receptor activation and functions as a co-activator
of Ucp1
a, Jhdm2a knockdown (KD) impairs ISO-induced Ucp1 transcriptional activation. Ctrl,
control. **P < 0.01. b, Defective ISO-induced Ucp1 activation caused by Jhdm2a
knockdown can be partially restored by JHDM2A overexpression *P < 0.05. c, qRT–PCR
(top panel) and western blot analysis (bottom panels) demonstrate that Jhdm2a is
upregulated by ISO in HIB1B cells. **P < 0.01. d, ChIP analysis demonstrates that Jhdm2a
directly binds to PPRE (amplicon A) of the Ucp1 enhancer after β-adrenergic stimulation. e,
ChIP analysis demonstrates that H3K9me2 at the Ucp1 gene enhancer is demethylated by
Jhdm2a after ISO treatment. The Jhdm2a knockdown-induced increase in H3K9me2 level
can be partially rescued by overexpression of JHDM2A coupled with ISO treatment. *P <
0.05. f, ChIP followed by qPCR indicates Jhdm2a knockdown impairs β-adrenergic receptor
activation-stimulated Pparγ and Rxrα recruitment to the PPRE of the Ucp1 gene enhancer.
Results are normalized to IgG, and are shown as the fold-enrichment relative to that in the
control cells without ISO. *P < 0.05. g, ChIP followed by qPCR indicates Jhdm2a
knockdown impairs β-adrenergic receptor activation-stimulated recruitment of Pparγ and
Rxrα co-activators Pgc1α, p300 and Src1 to the PPRE of the Ucp1 gene enhancer. Results
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are normalized to IgG, and are shown as fold of enrichment relative to that in the control
cells without ISO. *P < 0.05. Data are mean and s.e.m.
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